Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Quality in Primary Care
|
July 28, 2010
Musings on quality and organisational culture in primary care
Paul Milne
Pharmacoeconomics
|
February 8, 2013
PharmacoEconomics. Foreword
Christopher-Paul Milne
Food and Drug Law Journal
|
April 25, 2003
Exploring the frontiers of law and science: FDAMA's pediatric studies incentive
Christopher-Paul Milne
Personalized Medicine
|
May 23, 2018
Can translational medicine bring us out of the R&D wilderness?
Christopher-Paul Milne
Clinical Therapeutics
|
February 6, 2017
More Efficient Compliance with European Medicines Agency and Food and Drug Administration Regulations for Pediatric Oncology Drug Development: Problems and Solutions
Christopher-Paul Milne
Expert Opinion on Drug Discovery
|
March 20, 2013
US and European regulatory initiatives to improve R&D performance
Christopher-Paul Milne
Nature Biotechnology
|
July 31, 2002
Orphan products--pain relief for clinical development headaches
Christopher-Paul Milne
Current Opinion in Hematology
|
November 12, 2015
Langerhans cell origin and regulation
Matthew Collin, Paul Milne
Personalized Medicine
|
May 26, 2018
Biopharmaceutical industry perspectives on the business prospects for personalized medicine
Christopher-Paul Milne, Rachael Zuckerman
Journal of AOAC International
|
April 2, 2008
Determination of low-level pesticide residues in soft drinks and sports drinks by liquid chromatography with tandem mass spectrometry: collaborative study
Kathleen D Miller, Paul Milne
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Quality in Primary Care
|
July 28, 2010
Musings on quality and organisational culture in primary care
Paul Milne
Pharmacoeconomics
|
February 8, 2013
PharmacoEconomics. Foreword
Christopher-Paul Milne
Food and Drug Law Journal
|
April 25, 2003
Exploring the frontiers of law and science: FDAMA's pediatric studies incentive
Christopher-Paul Milne
Personalized Medicine
|
May 23, 2018
Can translational medicine bring us out of the R&D wilderness?
Christopher-Paul Milne
Clinical Therapeutics
|
February 6, 2017
More Efficient Compliance with European Medicines Agency and Food and Drug Administration Regulations for Pediatric Oncology Drug Development: Problems and Solutions
Christopher-Paul Milne
Expert Opinion on Drug Discovery
|
March 20, 2013
US and European regulatory initiatives to improve R&D performance
Christopher-Paul Milne
Nature Biotechnology
|
July 31, 2002
Orphan products--pain relief for clinical development headaches
Christopher-Paul Milne
Current Opinion in Hematology
|
November 12, 2015
Langerhans cell origin and regulation
Matthew Collin, Paul Milne
Personalized Medicine
|
May 26, 2018
Biopharmaceutical industry perspectives on the business prospects for personalized medicine
Christopher-Paul Milne, Rachael Zuckerman
Journal of AOAC International
|
April 2, 2008
Determination of low-level pesticide residues in soft drinks and sports drinks by liquid chromatography with tandem mass spectrometry: collaborative study
Kathleen D Miller, Paul Milne
Page
of 7